Senderowicz Adrian
SEC Form 4 insider trading activity
Senderowicz Adrian has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, Senderowicz Adrian is listed as Director at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, Senderowicz Adrian reported no open-market purchases and 1 open-market sale totaling $194K in PBYI.
Companies traded
Other insiders at PBYI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$194K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Senderowicz Adrian made?
Senderowicz Adrian has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Senderowicz Adrian trade?
Senderowicz Adrian has filed SEC Form 4 disclosures for 1 company, including PBYI.
When was Senderowicz Adrian's most recent SEC Form 4 filing?
Senderowicz Adrian's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is Senderowicz Adrian's total buy and sell value in the current window?
Inside the rolling retention window, Senderowicz Adrian bought $0 and sold $194K based on SEC Form 4 filings.
What was Senderowicz Adrian's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 27,000 PBYI shares on 2026-06-12, worth $194K, per SEC Form 4 filings.